Company Name:FibroGen Inc
CEO: Thomas B. Neff

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.


Key numbers

Market Capitalization:3227377500
Shares Outstanding: 87250000
Float: 77137288.75
Next Earning Date:2020-02-26
TTm EPS: 0.4901
TTm Dividend Rate:
200 days moving average:45.31
50 days moving average: 38.71
One day percent Change: -6.66



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,